The Ex-Timing trial: evaluating morning, afternoon, and evening exercise on the circadian clock in individuals with type 2 diabetes and overweight/obesity-a randomized crossover study protocol.


Journal

Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253

Informations de publication

Date de publication:
06 Aug 2024
Historique:
received: 02 04 2024
accepted: 11 07 2024
medline: 7 8 2024
pubmed: 7 8 2024
entrez: 6 8 2024
Statut: epublish

Résumé

Exercise is known to provide multiple metabolic benefits such as improved insulin sensitivity and glucose control in individuals with type 2 diabetes mellitus (T2DM) and those at risk. Beyond the traditional exercise dose, exercise timing is perceived as a contemporary hot topic, especially in the field of T2DM; however, the number of intervention studies assessing exercise timing and glucose metabolism is scarce. Our aim is to test the effect of exercise timing (i.e., morning, afternoon, or evening) on the inter-individual response variability in glycemic control and related metabolic health parameters in individuals with T2DM and those at risk during a 12-week intervention. A randomized crossover exercise intervention will be conducted involving two groups: group 1, individuals with T2DM; group 2, age-matched older adults with overweight/obesity. The intervention will consist of three 2-week blocks of supervised post-prandial exercise using high-intensity interval training (HIIT). Between each training block, a 2-week washout period, where participants avoid structured exercise, will take place. Assessments will be conducted in both groups before and after each exercise block. The primary outcomes include the 24-h area under the curve continuous glucose monitoring-based glucose. The secondary outcomes include body composition, resting energy expenditure, insulin response to a meal tolerance test, maximal aerobic capacity, peak power output, physical activity, sleep quality, and insulin and glucose levels. All primary and secondary outcomes will be measured at each assessment point. Outcomes from this trial will provide us additional insight into the role of exercise timing on the inter-individual response variability in glycemic control and other related metabolic parameters in two distinct populations, thus contributing to the development of more effective exercise prescription guidelines for individuals with T2DM and those at risk. ClinicalTrials.gov NCT06136013. Registered on November 18, 2023.

Sections du résumé

BACKGROUND BACKGROUND
Exercise is known to provide multiple metabolic benefits such as improved insulin sensitivity and glucose control in individuals with type 2 diabetes mellitus (T2DM) and those at risk. Beyond the traditional exercise dose, exercise timing is perceived as a contemporary hot topic, especially in the field of T2DM; however, the number of intervention studies assessing exercise timing and glucose metabolism is scarce. Our aim is to test the effect of exercise timing (i.e., morning, afternoon, or evening) on the inter-individual response variability in glycemic control and related metabolic health parameters in individuals with T2DM and those at risk during a 12-week intervention.
METHODS METHODS
A randomized crossover exercise intervention will be conducted involving two groups: group 1, individuals with T2DM; group 2, age-matched older adults with overweight/obesity. The intervention will consist of three 2-week blocks of supervised post-prandial exercise using high-intensity interval training (HIIT). Between each training block, a 2-week washout period, where participants avoid structured exercise, will take place. Assessments will be conducted in both groups before and after each exercise block. The primary outcomes include the 24-h area under the curve continuous glucose monitoring-based glucose. The secondary outcomes include body composition, resting energy expenditure, insulin response to a meal tolerance test, maximal aerobic capacity, peak power output, physical activity, sleep quality, and insulin and glucose levels. All primary and secondary outcomes will be measured at each assessment point.
DISCUSSION CONCLUSIONS
Outcomes from this trial will provide us additional insight into the role of exercise timing on the inter-individual response variability in glycemic control and other related metabolic parameters in two distinct populations, thus contributing to the development of more effective exercise prescription guidelines for individuals with T2DM and those at risk.
TRIAL REGISTRATION BACKGROUND
ClinicalTrials.gov NCT06136013. Registered on November 18, 2023.

Identifiants

pubmed: 39107793
doi: 10.1186/s13063-024-08335-y
pii: 10.1186/s13063-024-08335-y
doi:

Substances chimiques

Blood Glucose 0

Banques de données

ClinicalTrials.gov
['NCT06136013']

Types de publication

Journal Article Clinical Trial Protocol

Langues

eng

Sous-ensembles de citation

IM

Pagination

526

Subventions

Organisme : Fundação para a Ciência e a Tecnologia
ID : 2022.08130.PTDC

Informations de copyright

© 2024. The Author(s).

Références

Sun H, et al. IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119.
doi: 10.1016/j.diabres.2021.109119 pubmed: 34879977
Committee, A.D.A.P.P. 1. Improving care and promoting health in populations: standards of medical care in diabetes - 2022. Diabetes Care. 2021;45(Supplement_1):S8–16.
Davies MJ, et al. Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2022;45(11):2753–86.
doi: 10.2337/dci22-0034 pubmed: 36148880 pmcid: 10008140
Kanaley JA, et al. Exercise/physical activity in individuals with type 2 diabetes: a consensus statement from the American College of Sports Medicine. Med Sci Sports Exerc. 2022;54(2):353–68.
doi: 10.1249/MSS.0000000000002800 pubmed: 35029593 pmcid: 8802999
Savikj M, et al. Afternoon exercise is more efficacious than morning exercise at improving blood glucose levels in individuals with type 2 diabetes: a randomised crossover trial. Diabetologia. 2019;62(2):233–7.
doi: 10.1007/s00125-018-4767-z pubmed: 30426166
Solomon TPJ. Sources of inter-individual variability in the therapeutic response of blood glucose control to exercise in type 2 diabetes: going beyond exercise dose. Front Physiol. 2018;9:896.
doi: 10.3389/fphys.2018.00896 pubmed: 30061841 pmcid: 6055062
Montero D, Lundby C. Refuting the myth of non-response to exercise training: ‘non-responders’ do respond to higher dose of training. J Physiol. 2017;595(11):3377–87.
doi: 10.1113/JP273480 pubmed: 28133739 pmcid: 5451738
Magalhaes JP, et al. Effectiveness of high-intensity interval training combined with resistance training versus continuous moderate-intensity training combined with resistance training in patients with type 2 diabetes: a one-year randomized controlled trial. Diabetes Obes Metab. 2019;21(3):550–9.
doi: 10.1111/dom.13551 pubmed: 30284352
Liu JX, et al. Effectiveness of high-intensity interval training on glycemic control and cardiorespiratory fitness in patients with type 2 diabetes: a systematic review and meta-analysis. Aging Clin Exp Res. 2019;31(5):575–93.
doi: 10.1007/s40520-018-1012-z pubmed: 30097811
Gabriel BM, et al. Disrupted circadian oscillations in type 2 diabetes are linked to altered rhythmic mitochondrial metabolism in skeletal muscle. Sci Adv. 2021;7(43):eabi9654.
doi: 10.1126/sciadv.abi9654 pubmed: 34669477 pmcid: 8528429
Gabriel BM, Zierath JR. Circadian rhythms and exercise - re-setting the clock in metabolic disease. Nat Rev Endocrinol. 2019;15(4):197–206.
doi: 10.1038/s41574-018-0150-x pubmed: 30655625
Mason IC, et al. Impact of circadian disruption on glucose metabolism: implications for type 2 diabetes. Diabetologia. 2020;63(3):462–72.
doi: 10.1007/s00125-019-05059-6 pubmed: 31915891 pmcid: 7002226
Basse AL, et al. Skeletal muscle insulin sensitivity show circadian rhythmicity which is independent of exercise training status. Front Physiol. 2018;9:1198.
doi: 10.3389/fphys.2018.01198 pubmed: 30210362 pmcid: 6121032
Ezagouri S, et al. Physiological and molecular dissection of daily variance in exercise capacity. Cell Metab. 2019;30(1):78-91.e4.
doi: 10.1016/j.cmet.2019.03.012 pubmed: 31006590
Mancilla R, et al. Exercise training elicits superior metabolic effects when performed in the afternoon compared to morning in metabolically compromised humans. Physiol Rep. 2021;8(24):e14669.
doi: 10.14814/phy2.14669 pubmed: 33356015
Sui X, et al. Effects of cardiorespiratory fitness on aging: glucose trajectory in a cohort of healthy men. Ann Epidemiol. 2012;22(9):617–22.
doi: 10.1016/j.annepidem.2012.05.005 pubmed: 22763087 pmcid: 3723333
Teo SYM, et al. The effect of exercise timing on glycemic control: a randomized clinical trial. Med Sci Sports Exerc. 2020;52(2):323–34.
doi: 10.1249/MSS.0000000000002139 pubmed: 31479004
Borror A, et al. The effects of postprandial exercise on glucose control in individuals with type 2 diabetes: a systematic review. Sports Med. 2018;48(6):1479–91.
doi: 10.1007/s40279-018-0864-x pubmed: 29396781
Mayeuf-Louchart A, Staels B, Duez H. Skeletal muscle functions around the clock. Diabetes Obes Metab. 2015;17 Suppl 1:39–46.
doi: 10.1111/dom.12517 pubmed: 26332967
Magalhães JP, et al. Interindividual variability in fat mass response to a 1-year randomized controlled trial with different exercise intensities in type 2 diabetes: implications on glycemic control and vascular function. Front Physiol. 2021;12:698971.
doi: 10.3389/fphys.2021.698971 pubmed: 34603073 pmcid: 8481940
Júdice PB, et al. Sedentary behavior compensation to 1-year exercise RCT in patients with type 2 diabetes. Transl Sports Med. 2020;3:154–63.
doi: 10.1002/tsm2.96
Hetherington-Rauth M, Magalhães JP, Rosa GB, Correia IR, Carneiro T, Oliveira EC, Sardinha LB. Morning vs. afternoon physical activity and health-related outcomes in individuals with type 2 diabetes. Diabetes Obes Metab. 2022;24:1172-5.

Auteurs

João P Magalhães (JP)

Exercise and Health Laboratory, CIPER, Faculdade Motricidade Humana, Universidade Lisboa, Estrada da Costa, Cruz-Quebrada, 1499-688, Portugal. joao.magalhaes@campus.ul.pt.

Estela C Oliveira (EC)

Exercise and Health Laboratory, CIPER, Faculdade Motricidade Humana, Universidade Lisboa, Estrada da Costa, Cruz-Quebrada, 1499-688, Portugal.

Megan Hetherington-Rauth (M)

Exercise and Health Laboratory, CIPER, Faculdade Motricidade Humana, Universidade Lisboa, Estrada da Costa, Cruz-Quebrada, 1499-688, Portugal.

Filipe Jesus (F)

Exercise and Health Laboratory, CIPER, Faculdade Motricidade Humana, Universidade Lisboa, Estrada da Costa, Cruz-Quebrada, 1499-688, Portugal.

Maria Clarissa Rodrigues (MC)

Hospital de Santa Cruz, Centro Hospitalar Lisboa Ocidental, Departamento de Reabilitação Cardíaca, Lisbon, Portugal.

João F Raposo (JF)

Education and Research Centre, APDP-Diabetes Portugal (APDP-ERC), Rua Rodrigo da Fonseca 1, Lisbon, 1250-189, Portugal.

Rogério T Ribeiro (RT)

Education and Research Centre, APDP-Diabetes Portugal (APDP-ERC), Rua Rodrigo da Fonseca 1, Lisbon, 1250-189, Portugal.

Cristina Caetano (C)

Ginásio Clube Português, GCP Lab, Lisbon, Portugal.

Luís B Sardinha (LB)

Exercise and Health Laboratory, CIPER, Faculdade Motricidade Humana, Universidade Lisboa, Estrada da Costa, Cruz-Quebrada, 1499-688, Portugal.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH